PDL BioPharma (PDLI) Issues Clarification on Glumetza Royalty Rights (VRX)

November 6, 2015 9:02 AM

PDL BioPharma (NASDAQ: PDLI) issued financial results for the third quarter on Wednesday, November 4, 2015 and has subsequently received ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found